Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) Net Margin (2020 - 2025)

Historic Net Margin for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to 95.34%.

  • Stemtech's Net Margin fell 2087900.0% to 95.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 79.43%, marking a year-over-year decrease of 226200.0%. This contributed to the annual value of 74.65% for FY2024, which is 357200.0% up from last year.
  • As of Q3 2025, Stemtech's Net Margin stood at 95.34%, which was down 2087900.0% from 42.45% recorded in Q2 2025.
  • Stemtech's 5-year Net Margin high stood at 1660.53% for Q3 2022, and its period low was 1956.08% during Q2 2022.
  • Its 5-year average for Net Margin is 94.52%, with a median of 59.14% in 2024.
  • Within the past 5 years, the most significant YoY rise in Stemtech's Net Margin was 22464900bps (2022), while the steepest drop was -18806500bps (2022).
  • Stemtech's Net Margin (Quarter) stood at 64.62% in 2021, then increased by 22bps to 50.18% in 2022, then plummeted by -173bps to 136.88% in 2023, then soared by 78bps to 30.19% in 2024, then crashed by -216bps to 95.34% in 2025.
  • Its Net Margin stands at 95.34% for Q3 2025, versus 42.45% for Q2 2025 and 168.05% for Q1 2025.